Cargando…

Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant

AIMS: To investigate the epidemiological and prognostic relationship between heart failure with preserved ejection fraction (HFpEF) and left‐sided valve surgery using all‐cause mortality as a primary endpoint. METHODS AND RESULTS: We studied a total of 973 patients, of whom 673 had undergone left‐si...

Descripción completa

Detalles Bibliográficos
Autores principales: Kammerlander, Andreas A., Nitsche, Christian, Donà, Carolina, Koschutnik, Matthias, Dannenberg, Varius, Mascherbauer, Katharina, Schönbauer, Robert, Zafar, Amna, Winter, Max‐Paul, Bartko, Philipp E., Goliasch, Georg, Hengstenberg, Christian, Mascherbauer, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293454/
https://www.ncbi.nlm.nih.gov/pubmed/34506046
http://dx.doi.org/10.1002/ejhf.2345
_version_ 1784749635932258304
author Kammerlander, Andreas A.
Nitsche, Christian
Donà, Carolina
Koschutnik, Matthias
Dannenberg, Varius
Mascherbauer, Katharina
Schönbauer, Robert
Zafar, Amna
Winter, Max‐Paul
Bartko, Philipp E.
Goliasch, Georg
Hengstenberg, Christian
Mascherbauer, Julia
author_facet Kammerlander, Andreas A.
Nitsche, Christian
Donà, Carolina
Koschutnik, Matthias
Dannenberg, Varius
Mascherbauer, Katharina
Schönbauer, Robert
Zafar, Amna
Winter, Max‐Paul
Bartko, Philipp E.
Goliasch, Georg
Hengstenberg, Christian
Mascherbauer, Julia
author_sort Kammerlander, Andreas A.
collection PubMed
description AIMS: To investigate the epidemiological and prognostic relationship between heart failure with preserved ejection fraction (HFpEF) and left‐sided valve surgery using all‐cause mortality as a primary endpoint. METHODS AND RESULTS: We studied a total of 973 patients, of whom 673 had undergone left‐sided valve surgery (time from surgery to enrolment 50 ± 30 months after valve surgery) and 300 patients with HFpEF without prior surgery served as control group. Among patients after surgery, 67.4% fulfilled all criteria of HFpEF according to current guideline recommendations, 20.6% had no heart failure (HF), and 12.0% had HF with mid‐range or reduced ejection fraction (HFmrEF/HFrEF). During 83 ± 39 months of follow‐up, a total of 335 (34.4%) patients died. Compared to surgical patients with no subsequent HF, patients with HFpEF and HFmrEF/HFrEF after surgery showed significantly higher all‐cause mortality rates [hazard ratio (HR) 1.80, 95% confidence interval (CI) 1.25–2.57, P = 0.001; and HR 1.86, 95% CI 1.16–2.98, P = 0.010, respectively]. This increased mortality rate was similar to the control HFpEF group without surgery (HR 2.05, 95% CI 1.38–3.02, P < 0.001). Results remained consistent after adjustment for clinical and imaging risk factors and when using the established HFA‐PEFF risk score for HFpEF diagnosis. Notably, only 12.5% of HFpEF patients after surgery were diagnosed with HF despite regular follow‐up visits by board‐certified cardiologists. In contrast, 92.1% of HFmrEF/HFrEF patients after surgery were diagnosed correctly. CONCLUSIONS: Heart failure with preserved ejection fraction following left‐sided valve surgery is highly prevalent, associated with unfavourable outcomes, but rarely recognized.
format Online
Article
Text
id pubmed-9293454
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Ltd.
record_format MEDLINE/PubMed
spelling pubmed-92934542022-07-20 Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant Kammerlander, Andreas A. Nitsche, Christian Donà, Carolina Koschutnik, Matthias Dannenberg, Varius Mascherbauer, Katharina Schönbauer, Robert Zafar, Amna Winter, Max‐Paul Bartko, Philipp E. Goliasch, Georg Hengstenberg, Christian Mascherbauer, Julia Eur J Heart Fail Valvular Heart Disease AIMS: To investigate the epidemiological and prognostic relationship between heart failure with preserved ejection fraction (HFpEF) and left‐sided valve surgery using all‐cause mortality as a primary endpoint. METHODS AND RESULTS: We studied a total of 973 patients, of whom 673 had undergone left‐sided valve surgery (time from surgery to enrolment 50 ± 30 months after valve surgery) and 300 patients with HFpEF without prior surgery served as control group. Among patients after surgery, 67.4% fulfilled all criteria of HFpEF according to current guideline recommendations, 20.6% had no heart failure (HF), and 12.0% had HF with mid‐range or reduced ejection fraction (HFmrEF/HFrEF). During 83 ± 39 months of follow‐up, a total of 335 (34.4%) patients died. Compared to surgical patients with no subsequent HF, patients with HFpEF and HFmrEF/HFrEF after surgery showed significantly higher all‐cause mortality rates [hazard ratio (HR) 1.80, 95% confidence interval (CI) 1.25–2.57, P = 0.001; and HR 1.86, 95% CI 1.16–2.98, P = 0.010, respectively]. This increased mortality rate was similar to the control HFpEF group without surgery (HR 2.05, 95% CI 1.38–3.02, P < 0.001). Results remained consistent after adjustment for clinical and imaging risk factors and when using the established HFA‐PEFF risk score for HFpEF diagnosis. Notably, only 12.5% of HFpEF patients after surgery were diagnosed with HF despite regular follow‐up visits by board‐certified cardiologists. In contrast, 92.1% of HFmrEF/HFrEF patients after surgery were diagnosed correctly. CONCLUSIONS: Heart failure with preserved ejection fraction following left‐sided valve surgery is highly prevalent, associated with unfavourable outcomes, but rarely recognized. John Wiley & Sons, Ltd. 2021-10-04 2021-12 /pmc/articles/PMC9293454/ /pubmed/34506046 http://dx.doi.org/10.1002/ejhf.2345 Text en © 2021 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Valvular Heart Disease
Kammerlander, Andreas A.
Nitsche, Christian
Donà, Carolina
Koschutnik, Matthias
Dannenberg, Varius
Mascherbauer, Katharina
Schönbauer, Robert
Zafar, Amna
Winter, Max‐Paul
Bartko, Philipp E.
Goliasch, Georg
Hengstenberg, Christian
Mascherbauer, Julia
Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant
title Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant
title_full Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant
title_fullStr Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant
title_full_unstemmed Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant
title_short Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant
title_sort heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevant
topic Valvular Heart Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293454/
https://www.ncbi.nlm.nih.gov/pubmed/34506046
http://dx.doi.org/10.1002/ejhf.2345
work_keys_str_mv AT kammerlanderandreasa heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT nitschechristian heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT donacarolina heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT koschutnikmatthias heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT dannenbergvarius heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT mascherbauerkatharina heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT schonbauerrobert heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT zafaramna heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT wintermaxpaul heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT bartkophilippe heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT goliaschgeorg heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT hengstenbergchristian heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant
AT mascherbauerjulia heartfailurewithpreservedejectionfractionafterleftsidedvalvesurgeryprevalentandrelevant